{"PubmedArticle":{"MedlineCitation":{"@attributes":{"Status":"PubMed-not-MEDLINE","Owner":"NLM"},"PMID":{"@attributes":{"Version":"1"},"@text":"31406593"},"DateRevised":{"Year":"2020","Month":"02","Day":"25"},"Article":{"@attributes":{"PubModel":"Electronic-eCollection"},"Journal":{"ISSN":{"@attributes":{"IssnType":"Print"},"@text":"2059-7908"},"JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"4","Issue":"4","PubDate":{"Year":"2019"}},"Title":"BMJ global health","ISOAbbreviation":"BMJ Glob Health"},"ArticleTitle":"The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists.","Pagination":{"StartPage":"e001681","MedlinePgn":"e001681"},"ELocationID":[{"@attributes":{"EIdType":"pii","ValidYN":"Y"},"@text":"e001681"},{"@attributes":{"EIdType":"doi","ValidYN":"Y"},"@text":"10.1136\/bmjgh-2019-001681"}],"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Ferrario","ForeName":"Alessandra","Initials":"A","Identifier":[{"@attributes":{"Source":"ORCID"},"@text":"0000-0002-1572-3581"}],"AffiliationInfo":[{"Affiliation":"Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, United States of America."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Orubu","ForeName":"Ebiowei Samuel F","Initials":"ESF","AffiliationInfo":[{"Affiliation":"Institute for Health System Innovation and Policy, Boston University, Boston, Massachusetts, United States of America."},{"Affiliation":"Faculty of Pharmacy, Niger Delta University, Amassoma, Nigeria."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Adeyeye","ForeName":"Moji Christianah","Initials":"MC","AffiliationInfo":[{"Affiliation":"Director-General, National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Zaman","ForeName":"Muhammad H","Initials":"MH","AffiliationInfo":[{"Affiliation":"Department of Biomedical Engineering and Howard Hughes Medical Institute, Boston University, Boston, Massachusetts, United States of America."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Wirtz","ForeName":"Veronika J","Initials":"VJ","AffiliationInfo":[{"Affiliation":"Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America."}]}]},"Language":["eng"],"PublicationTypeList":{"PublicationType":[{"@attributes":{"UI":"D016421"},"@text":"Editorial"}]},"ArticleDate":[{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"07","Day":"18"}]},"MedlineJournalInfo":{"Country":"England","MedlineTA":"BMJ Glob Health","NlmUniqueID":"101685275","ISSNLinking":"2059-7908"},"KeywordList":[{"@attributes":{"Owner":"NOTNLM"},"Keyword":[{"@attributes":{"MajorTopicYN":"N"},"@text":"public health"}]}],"CoiStatement":"Competing interests: VJW reports grants from International Federation of the Pharmaceutical Manufacturer Associations (IFPMA), grants from Sandoz International GmbH and grants from Gilead Inc., outside the submitted work."},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2019","Month":"5","Day":"1"},{"@attributes":{"PubStatus":"revised"},"Year":"2019","Month":"6","Day":"2"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"6","Day":"8"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"8","Day":"14","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"8","Day":"14","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"8","Day":"14","Hour":"6","Minute":"1"},{"@attributes":{"PubStatus":"pmc-release"},"Year":"2019","Month":"7","Day":"18"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"31406593"},{"@attributes":{"IdType":"pmc"},"@text":"PMC6666819"},{"@attributes":{"IdType":"doi"},"@text":"10.1136\/bmjgh-2019-001681"},{"@attributes":{"IdType":"pii"},"@text":"bmjgh-2019-001681"}]},"ReferenceList":[{"Reference":[{"Citation":"A study on the public health and socioeconomic impact of substandard and falsified medical product. Geneva: World Health Organization; 2017."},{"Citation":"Ozawa S, Evans DR, Bessias S, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis. JAMA Netw Open 2018;1:e181662 10.1001\/jamanetworkopen.2018.1662","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.1001\/jamanetworkopen.2018.1662"},{"@attributes":{"IdType":"pmc"},"@text":"PMC6324280"},{"@attributes":{"IdType":"pubmed"},"@text":"30646106"}]}},{"Citation":"Kelesidis T, Falagas ME. Substandard\/counterfeit antimicrobial drugs. Clin Microbiol Rev 2015;28:443\u201364. 10.1128\/CMR.00072-14","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.1128\/CMR.00072-14"},{"@attributes":{"IdType":"pmc"},"@text":"PMC4402958"},{"@attributes":{"IdType":"pubmed"},"@text":"25788516"}]}},{"Citation":"Venhuis BJ, Oostlander AE, Giorgio DD, et al. Oncology drugs in the crosshairs of pharmaceutical crime. Lancet Oncol 2018;19:e209\u201317. 10.1016\/S1470-2045(18)30101-3","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.1016\/S1470-2045(18)30101-3"},{"@attributes":{"IdType":"pubmed"},"@text":"29611529"}]}},{"Citation":"Zaman MH. Bitter pills: the global war on counterfeit drugs. Oxford University Press, 2018."},{"Citation":"Tabernero P, Fern\u00e1ndez FM, Green M, et al. Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world\u2014analysis of the WorldWide Antimalarial Resistance Network database. Malar J 2014;13 10.1186\/1475-2875-13-139","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.1186\/1475-2875-13-139"},{"@attributes":{"IdType":"pmc"},"@text":"PMC4021408"},{"@attributes":{"IdType":"pubmed"},"@text":"24712972"}]}},{"Citation":"Institute of Medicine Countering the problem of falsified and substandard drugs. Washington, DC: The National Academies Press, 2013.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"24872973"}]}},{"Citation":"Definitions of substandard and falsified (SF) medical products. World Health Organization. Available: http:\/\/www.who.int\/medicines\/regulation\/ssffc\/definitions\/en [Accessed 25\/06\/2019]."},{"Citation":"Hamilton WL, Doyle C, Halliwell-Ewen M, et al. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Health Policy Plan 2016;31:1448\u201366. 10.1093\/heapol\/czw062","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.1093\/heapol\/czw062"},{"@attributes":{"IdType":"pubmed"},"@text":"27311827"}]}},{"Citation":"Member state mechanism onsubstandard\/spurious\/falsely-labelled\/falsified\/counterfeit medical products. Geneva: \nWorld Health organization; 2017. \nhttp:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA70\/A70_23-en.pdf\n[Accessed 26 Jun 2019]."},{"Citation":"Ravinetto R, Vandenbergh D, Mac\u00e9 C, et al. Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy. J Pharm Policy Pract 2016;9 10.1186\/s40545-016-0088-0","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.1186\/s40545-016-0088-0"},{"@attributes":{"IdType":"pmc"},"@text":"PMC5105267"},{"@attributes":{"IdType":"pubmed"},"@text":"27843547"}]}},{"Citation":"International Pharmaceutical Federation Pharmacists in the supply chain: The role of the medicines expert in ensuring quality and availability. The Hague, the Netherlands: International Pharmaceutical Federation (FIP); 2017."},{"Citation":"Pisani E, Nistor A-L, Hasnida A, et al. Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania. Wellcome Open Res 2019;4 10.12688\/wellcomeopenres.15236.1","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.12688\/wellcomeopenres.15236.1"},{"@attributes":{"IdType":"pmc"},"@text":"PMC6518437"},{"@attributes":{"IdType":"pubmed"},"@text":"31131333"}]}},{"Citation":"The Lancet respiratory medicine Fake medicines: fighting on all fronts. Lancet Respir Med 2018;6.","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"pubmed"},"@text":"29653806"}]}},{"Citation":"Ferrario A, Wirtz VJ, Zaman MH. Education about substandard and falsified medicines: a review of Bachelor in Pharmacy curricula in six countries : Abstract book. Medicine Quality& Public Health Conference.. Oxford, 2018: 29."},{"Citation":"Pyzik O. Global Pharmacy Education & UCL Fight the Fakes : Abstract book. Medicine Quality& Public Health Conference. Oxford, 2018: 28\u201329."},{"Citation":"USP Promoting the quality of medicines: annual performance report 2018. Rockville, MD: U.S. Pharmacopeial Convention, 2018."},{"Citation":"Fittler A, Vida RG, R\u00e1dics V, et al. A challenge for healthcare but just another opportunity for illegitimate online sellers: dubious market of shortage oncology drugs. PLoS One 2018;13:e0203185 10.1371\/journal.pone.0203185","ArticleIdList":{"ArticleId":[{"@attributes":{"IdType":"doi"},"@text":"10.1371\/journal.pone.0203185"},{"@attributes":{"IdType":"pmc"},"@text":"PMC6112670"},{"@attributes":{"IdType":"pubmed"},"@text":"30153304"}]}},{"Citation":"FDA \nHealth care provider alert: another counterfeit cancer medicine found in United States, 2018.  Available: http:\/\/www.fda.gov\/drugs\/counterfeit-medicine\/health-care-provider-alert-another-counterfeit-cancer-medicine-found-united-states [Accessed 28 May 2019]."}]}]}}}